Product Information
PULMOZYME 1 MG/ML AMPUL is a brand product labeled by Genentech, Inc., priced at $53.1569 per ML under NDC 50242010040. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
1 mg/mL
Manufacturer
Genentech, Inc.NDC
50242010040
Classification
Brand
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
DORNASE ALFAApproval Type
Biologic (BLA)
FDA Application
BLA103532On Market Since
12/30/1993
Pharmacological Classes
Price Statistics
The NADAC for PULMOZYME 1 MG/ML AMPUL has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 71.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $53.1569 per ML |
|---|---|
| All-time high | $53.2504 (May 13, 2026) |
| All-time low | $30.6545 (Dec 18, 2013) |
| 52-week high | $53.2504 |
| 52-week low | $51.5666 |
| Median price | $44.6138 |
| Average price | $44.3191 |
| Largest weekly change | +9.0% (Jan 13, 2016) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dornase alfa market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Genentech, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dornase alfa market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PULMOZYME 1 MG/ML AMPUL?
The current National Average Drug Acquisition Cost (NADAC) for PULMOZYME 1 MG/ML AMPUL, manufactured by Genentech, Inc., is $53.1569 per ML (NDC 50242010040), effective Sep 30, 2026.
How has the price of PULMOZYME 1 MG/ML AMPUL changed over time?
Over the history we have for it, the NADAC for PULMOZYME 1 MG/ML AMPUL has risen 71.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PULMOZYME 1 MG/ML AMPUL?
Since Nov 28, 2013, the NADAC for PULMOZYME 1 MG/ML AMPUL has ranged from a low of $30.6545 (Dec 18, 2013) to a high of $53.2504 (May 13, 2026), with a median of $44.6138 per ML.
Are there cheaper alternatives to PULMOZYME 1 MG/ML AMPUL?
No other NADAC-published product currently shares the active ingredient and strength of PULMOZYME 1 MG/ML AMPUL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PULMOZYME 1 MG/ML AMPUL?
PULMOZYME 1 MG/ML AMPUL (NDC 50242010040) is labeled by Genentech, Inc., and CMS classifies it as a brand product.